AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIAID

NIH’s Dr. Carl Dieffenbach Shares a Highlight from Day 3 of AIDS 2014 on Making Better, Smarter Investments to Achieve AIDS-Free Generation

dybul

This week, we’ve asked Dr. Carl Dieffenbach from NIH/NIAID to share daily science highlights from the 20th International AIDS Conference (AIDS 2014) in Melbourne, Australia. His highlight today was a presentation by Ambassador Mark Dybul, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, about how better and smarter investments can bring…

NIH’s Dr. Carl Dieffenbach Looks Ahead to Key Topics to be Explored at AIDS 2014

Carl Dieffenbach Day 1 AIDS 2014

As the 20th International AIDS Conference (AIDS 2014) opened in Melbourne, Australia on Sunday, July 20, 2014, we had the chance to speak with Dr. Carl Dieffenbach. He’s the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). During our brief conversation, Dr. Dieffenbach reflects on the conference theme, “Stepping…

” We have the aspiration of a cure”: Dr. Anthony Fauci speaks to AIDS.gov about the Mississippi Baby

Fauci

“We have better treatments, we have the aspiration of a cure, and we have prevention, particularly in the form of a vaccine. So the research agenda has a lot of possibilities and we are still striving…”- Dr. Anthony Fauci Last Friday, July 11, we sat down with Dr. Anthony Fauci, Director of the National Institutes…

Interview with Dr. Anthony Fauci on “Mississippi Baby”

Dr. Fauci

In an important announcement yesterday, Thursday, July 10, the National Institutes of Health (NIH) reported that the child known as the “Mississippi Baby”—an infant seemingly cured of HIV after treatment had been initiated within hours of birth—now has detectable levels of HIV after more than two years of not taking antiretroviral therapy without evidence of the…

“Mississippi Baby” Now Has Detectable HIV, Researchers Find

nih logo

The child known as the “Mississippi baby”—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable levels of HIV after more than two years of not taking antiretroviral therapy without evidence of virus, according to the pediatric…

HIV Vaccine Awareness Day

Dr. Anthony Fauci

Watch NIAID Director Anthony S. Fauci, M.D., discuss current HIV vaccine research approaches. Developing a safe and sufficiently effective HIV vaccine is essential if we are to achieve a timely and durable end to the global HIV/AIDS pandemic. The path to an HIV vaccine has not been—and will not be—an easy one. In the 27…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 5

Ron Valdiserri and Carl Dieffenbach

At the conclusion of sessions yesterday, March 5, at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, NIH’s Dr. Carl Dieffenbach sat down with Dr. Ron Valdiserri to discuss some of the day’s scientific highlights. In their video conversation below, Dr. Dieffenbach observes that three significant advances in HIV therapies were among…

NIH Seeks Input on HIV Cure Research Priorities

nih logo

The National Institutes of Health (NIH) is asking the scientific community to weigh in on what should be the highest priority research areas related to understanding HIV persistence and investigating strategies for eradicating or controlling remaining virus despite optimal antiretroviral treatment. Responses will be accepted through March 14 and will help guide the HIV Cure Initiative, a $100 million…